000 01490 a2200433 4500
005 20250513081715.0
264 0 _c19930525
008 199305s 0 0 eng d
022 _a0270-9139
024 7 _a10.1002/hep.1840170408
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPoupon, R E
245 0 0 _aCholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis.
_h[electronic resource]
260 _bHepatology (Baltimore, Md.)
_cApr 1993
300 _a577-82 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAnticholesteremic Agents
_xtherapeutic use
650 0 4 _aBile Acids and Salts
_xblood
650 0 4 _aCholesterol
_xblood
650 0 4 _aCholesterol, HDL
_xblood
650 0 4 _aCholesterol, LDL
_xblood
650 0 4 _aDouble-Blind Method
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aLiver Cirrhosis, Biliary
_xblood
650 0 4 _aLiver Function Tests
650 0 4 _aMiddle Aged
650 0 4 _aPlacebos
650 0 4 _aTime Factors
650 0 4 _aUrsodeoxycholic Acid
_xtherapeutic use
700 1 _aOuguerram, K
700 1 _aChrétien, Y
700 1 _aVerneau, C
700 1 _aEschwège, E
700 1 _aMagot, T
700 1 _aPoupon, R
773 0 _tHepatology (Baltimore, Md.)
_gvol. 17
_gno. 4
_gp. 577-82
856 4 0 _uhttps://doi.org/10.1002/hep.1840170408
_zAvailable from publisher's website
999 _c8477232
_d8477232